Pretest - Tumor Board Tuesday - July 13, 2021 (ID: i788-13)

Question Title

* 1. Please list your last name and zip code:

Last name:

ZIP/Postal Code:

Question Title

* 2. What is your specialty?

Question Title

* 3. How many patients with upper gastrointestinal cancer do you treat each week?

1 to 10

11 to 25

26 to 50

I am not directly involved in patient care

Question Title

* 4. Which of the following FGFR inhibitors is not FDA approved in cholangiocarcinoma?

Pemigatinib

Erdafitinib

Infigratinib (BGJ398)

Question Title

* 5. Next generation sequencing is not indicated in patients with metastatic intrahepatic cholangiocarcinoma.

True

False